Young Bae Park,Hyo Soo Kim,Jin Hur,Jae Il Choi,Ji Yeon Yun
申请号：
US14372891
公开号：
US20150157663A1
申请日:
2013.01.18
申请国别(地区):
US
年份:
2015
代理人:
摘要：
There are provided a pharmaceutical composition for treating immune-related diseases, a pharmaceutical composition for treating ischemic diseases, a pharmaceutical composition for promoting lymphangiogenesis, a pharmaceutical composition for treating neurological diseases, a pharmaceutical composition for treating metabolic diseases, and the like, which contain blood-born hematospheres, and more specifically, may differentiate into inflammatory mononuclear cells, vascular endothelial cells, vascular smooth muscle cells, lymphatic vessel adult stem cells and progenitor cells, neural progenitor cells and nerve cells, insulin secreting cells, and the like by effective 3D culturing using blood mononuclear cells. Therefore, the present invention is expected to be used for development of a cell therapeutic agent for various types of diseases. Also, when blood-born hematospheres according to the present invention are used, it is possible to address previous problems associated with development of a stem cell therapeutic agent such as tumor occurrence, immune rejection, ethical issues, and difficult differentiation methods.
